Lv6
2620 积分 2023-12-04 加入
Topoisomerase I inhibitors: Challenges, progress and the road ahead
14天前
已完结
Topoisomerase I/II inhibitors: from established drugs to next-generation therapeutics
14天前
已完结
Recent progress in topoisomerase inhibitors as anticancer agents: Research and design strategies for Topo I and II inhibitors via structural optimization
14天前
已完结
Doxorubicin prodrug-based nanomedicines for the treatment of cancer
15天前
已完结
External triggering and triggered targeting strategies for drug delivery
20天前
已完结
Progress, challenges, and future of nanomedicine
25天前
已完结
X‐ray controlled release strategy in cancer therapy
1个月前
已完结
Radiotherapy-Activated Prodrug: Past, Present and Beyond
1个月前
已完结
Efficient active hydrogen delivery for drug-free radiation enteritis therapy in mice
2个月前
已完结
A ferroptosis-targeting ceria anchored halloysite as orally drug delivery system for radiation colitis therapy
2个月前
已完结
皖公网安备34019202002308
